- Joined
- Aug 21, 2002
- Messages
- 4,049
- Reaction score
- 3
I'm suprised this has not been asked on this forum yet. As many of you no doubt know, a clinical trial for a new HPV vaccine just punlished last week and by all accounts, it cuts infection by close to 100%. By all other accounts, HPV is intimately (if not inextricably) associated with cervical dysplasia and, if untreated, cervical cancer.
Two questions:
If most cases of cervical cancer, cervical dysplasia, CIS, whatever, go the way of the carrier pigeon, what impact will that have on the basic practice of an OB/GYN - many of whom (as I understand it) do not only most of the pap smears in the country, but also most of the leep procedures (and even cold knife biopsies/cones, etc.)?
Secondly, assuming that this sort of work does NOT represent a significant chunk of the OB/GYN's revenue stream, doesn't the anual pap smear also represent ONE OF the MAJOR reasons a woman comes into the see an OB/GYN on a yearly basis anyway (call it a "gateway" procedure).
What does this new vaccine protend for the profession? For the Gyn/Onc people?
Judd
Two questions:
If most cases of cervical cancer, cervical dysplasia, CIS, whatever, go the way of the carrier pigeon, what impact will that have on the basic practice of an OB/GYN - many of whom (as I understand it) do not only most of the pap smears in the country, but also most of the leep procedures (and even cold knife biopsies/cones, etc.)?
Secondly, assuming that this sort of work does NOT represent a significant chunk of the OB/GYN's revenue stream, doesn't the anual pap smear also represent ONE OF the MAJOR reasons a woman comes into the see an OB/GYN on a yearly basis anyway (call it a "gateway" procedure).
What does this new vaccine protend for the profession? For the Gyn/Onc people?
Judd